Calidi Biotherapeutics, Inc. - CLDI
Sector:
Healthcare
· Industry:
Biological Products, (No Diagnostic Substances)
Website:
No information yet
· Social:
No information yet
Company profile
Powered by TradingView
Quarter snapshot
Latest / Compare
Q1 2026
· Q4 2025
Value (USD)
Total reported value ($000)
$510K
QoQ value delta ($000)
-$5K
(-0.97%)
Implied price effect (QoQ)
-78.26%
Shares
Total shares
2,042,608
QoQ shares delta
+1,594,285
(+355.61%)
Total shares held by funds (by quarter)
Market chart (CLDI)
Powered by TradingView
Interactive chart by
TradingView.
Top holders (Q1 2026)
Top 25 only
Full list
Partial Q1 2026 data: 28 holders have filed so far. Prior holders are carried forward until their next 13F confirms a change.
| Manager | Value ($000) | Shares | % of 13F |
|---|---|---|---|
| ARMISTICE CAPITAL, LLC | 209 | 879,000 | 0.0% |
| SABBY MANAGEMENT, LLC | 103 | 434,903 | 0.23% |
| Warberg Asset Management LLC | 59 | 250,000 | 0.01% |
| VANGUARD GROUP INC | 40 | 34,728 | 0.0% |
| HighTower Advisors, LLC | 19 | 83,523 | 0.0% |
| Virtu Financial LLC | 18 | 75,769 | 0.0% |
| GEODE CAPITAL MANAGEMENT, LLC | 15 | 63,019 | 0.0% |
| RS CRUM INC. | 9 | 40,256 | 0.0% |
| JANE STREET GROUP, LLC | 8 | 34,802 | 0.0% |
| Arax Advisory Partners | 8 | 37,345 | 0.0% |
| VANGUARD CAPITAL MANAGEMENT LLC | 6 | 25,509 | 0.0% |
| NORTHERN TRUST CORP | 4 | 17,758 | 0.0% |
| Belpointe Asset Management LLC | 4 | 19,921 | 0.0% |
| MORGAN STANLEY | 2 | 9,467 | 0.0% |
| Farther Finance Advisors, LLC | 2 | 10,000 | 0.0% |
| VANGUARD FIDUCIARY TRUST CO | 2 | 9,219 | 0.0% |
| HRT FINANCIAL LP | 2 | 10,133 | 0.0% |
| FMR LLC | 0 | 255 | 0.0% |
| CITIGROUP INC | 0 | 14 | 0.0% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 0 | 1,042 | 0.0% |
| EVERMAY WEALTH MANAGEMENT LLC | 0 | 1 | 0.0% |
| Apollo Management Holdings, L.P. | 0 | 1,042 | 0.0% |
| Tower Research Capital LLC (TRC) | 0 | 1,396 | 0.0% |
| Finepoint Capital LP | 0 | 1,042 | 0.0% |
| Tradewinds Capital Management, LLC | 0 | 101 | 0.0% |